CDIO

CDIO

USD

Cardio Diagnostics Holdings Inc. Common stock

$0.484-0.066 (-12.000%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.550

Haut

$0.560

Bas

$0.458

Volume

0.03M

Fondamentaux de l'Entreprise

Capitalisation Boursière

27.1M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.30M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.19Actuel $0.484Haut $1.77

Rapport d'Analyse IA

Dernière mise à jour: 13 avr. 2025
Généré par l'IASource des Données: Yahoo Finance, Bloomberg, SEC

[CDIO: Cardio Diagnostics Holdings Inc. Common stock]: Checking the Pulse - Is There a Beat?

Stock Symbol: CDIO Generate Date: 2025-04-13 06:31:24

Let's take a look at Cardio Diagnostics (CDIO). This is a biotech company focused on heart disease diagnostics, which is a pretty big and important area. We've got some recent news, price history, and even what an AI thinks might happen. So, what's the story here for someone just trying to understand if this stock is interesting right now?

Recent News Buzz: Positive Vibes from a Big Conference

The latest news is actually pretty upbeat. Cardio Diagnostics announced they're going to be at a major cardiology conference, the American College of Cardiology's big annual meeting. They're planning to show off some of their key products, like "PrecisionCHD" and "Actionable Clinical Intelligence," along with some new stuff.

What does this mean? Basically, it's like a company going to a big industry event to show off their latest gadgets. It's a chance to get attention, talk to doctors and other professionals, and maybe drum up some interest in their tests. So, the feeling around this news is definitely positive. It suggests they're actively promoting their technology and trying to grow their business.

Price Check: A Bit of a Rollercoaster Lately

Now, let's peek at the stock price. Over the last month or so, it's been a bit of a bumpy ride. If you look back, say to mid-January, the price was higher, around the $0.60-$0.70 range at times. But then it generally drifted downwards, hitting lows in late March and early April, even dipping below $0.30 recently. That's a pretty noticeable drop.

However, if you look at the very recent days, like the last few trading days, there's been a slight bounce back up from those lows. It's currently hovering around $0.35, after touching $0.41 just yesterday. So, it's not a straight line down anymore, but it's definitely still lower than it was a month or two ago.

Interestingly, AI predictions for the very short term (today and the next couple of days) are slightly positive, suggesting a small potential uptick. Nothing huge, but maybe a hint that the recent downward pressure might be easing.

Outlook & Ideas: Is it Time to Pay Attention?

Putting it all together, what can we make of this? We've got positive news about the company showcasing their tech, which is good for sentiment. The stock price has been down, but there are signs of a possible bottoming out and maybe even a slight recovery in the very short term, according to AI predictions.

So, what's the leaning? Right now, it might be starting to look a little more interesting for potential buyers, or at least less scary for current holders. The positive news and potential price stabilization could suggest a possible window to consider accumulating shares, if you're comfortable with risk.

Potential Entry Consideration: If you were thinking about getting in, the current price range, around $0.35, could be an area to watch. It's near the recent lows, and if the predicted slight upward trend plays out, it might offer a decent entry point. You could also consider waiting to see if it dips slightly again, maybe towards $0.34, to try and get in a bit lower.

Potential Exit/Stop-Loss Consideration: Because it's still a bit uncertain, and the stock has been volatile, having a stop-loss is probably a smart idea. A level below the recent lows, perhaps around $0.30 or even a bit lower at $0.28, could be a point to consider if things turn south again. On the upside, if the stock does start to move up, a potential initial profit target could be around $0.47, which has acted as resistance in the past. These are just potential levels to think about for managing risk.

Company Context Matters: Remember, Cardio Diagnostics is a smaller biotech company. They're in the business of developing and selling diagnostic tests. News about their technology and adoption is going to be key. Their market cap is relatively small, and the stock can be sensitive to market swings. The fact they are in the biotechnology and healthcare sectors is also important to keep in mind, as these sectors can have their own specific trends and risks.

In short: CDIO is showing some signs of life after a recent price drop, supported by positive news and short-term AI predictions. It's still a higher-risk stock, but for those with an appetite for that, it might be worth watching for a potential short-term trade. Keep a close eye on price action and any further news.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. The stock market is inherently risky, and prices can fluctuate significantly. Investors should conduct their own thorough research and/or consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Actualités Connexes

BusinessWire

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, today announced its participation in the American College of Cardiology's 74th Annual Scientific Session &

Voir plus
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

Prédiction IABeta

Recommandation IA

Haussier

Mis à jour le: 28 avr. 2025, 10:10

BaissierNeutreHaussier

59.2% Confiance

Risque et Trading

Niveau de Risque4/5
Risque Élevé
Adapté Pour
ValeurAgressif
Guide de Trading

Point d'Entrée

$0.48

Prise de Bénéfices

$0.58

Stop Loss

$0.43

Facteurs Clés

Le DMI montre une tendance baissière (ADX:17.7, +DI:20.2, -DI:24.6), suggérant la prudence
Le cours actuel est extrêmement proche du niveau de support ($0.48), suggérant une forte opportunité d'achat
Le MACD -0.0034 est en dessous de la ligne de signal -0.0029, indiquant un croisement baissier

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.